Did Omicron originate in MICE? Researchers say analysis suggests extremely-transmissible variant evolved in rodents before jumping back to humans
- Chinese scientists say Omicron’s DNA suggest it first emerged in mice
- They said it has mutations that made it better able to infect the animal group
- But most scientists say it likely emerged in an immunocompromised patient
Omicron could have jumped into humans from mice, scientists say.
The mysterious origin of the heavily-mutated Covid variant that triggered global panic only a month ago continues to puzzle experts.
But Chinese scientists now say they may have unearthed evidence linking the mutant strain to mice — in its DNA.
Analysis showed the variant carries mutations that make it better at infecting the animal group — which previous research has shown can catch Covid from humans.
And that it has many more mutations than any other mutant strains, which the scientists held up as yet more proof it did not emerge in humans.
This is not the first time experts have raised the prospect that the variant first appeared in rodents before jumping back into humans.
But most scientists agree that Omicron likely emerged after a prolonged infection in an immunocompromised person, such as an HIV patient.
Some scientists argue that Omicron evolved in mice before jumping back into humans (stock picture). Others say, however, that it likely emerged in an immunocompromised patient
In the study, researchers compared the DNA of Omicron to the original Wuhan virus and other variants including Alpha and Delta which sparked last summer’s wave.
They found it had a much higher average number of mutations (53.3) than other mutant strains (28.4 to 35.4).
And that its closest relative was the Gamma variant — which emerged in Brazil — although the two split into separate groups in mid-2020.
Scientist claim ‘weird’ mutations suggest Omicron jumped back and forth between animals and people
Professor Kristian Andersen, an immunologist at the Scripps Research Institute in California, has theorised that the virus that would become Omicron may have evolved in rodents – known to be carriers of the coronavirus – after an infected human passed the virus to them.
Professor Andersen based the theory on the fact that while Omicron diverged from other Covid variants in the middle of last year, genomic sampling suggested it only started circulating in people sometime in October this year.
What happened in between these two periods is the mystery behind what has made Omicron so different.
While adding that this is only theoretical Professor Andersen said in a Twitter post he favoured a zoonic, animal-based, origin for Omicron as ‘the lineage is old and undetected circulation in immunocompromised patient(s) for this long seems unlikely’ and that Covid has been shown to jump between species previously.
Secondly, is that several of Omicron’s mutations have also been in rodent species such as mice and hamsters.
This ‘long branch’, the scientists said, suggested it ‘may have evolved in a non-human animal species’.
They also compared Omicron to mutations in 13 little-known Covid strains that had previously been found to infect mice.
Results showed it shared five mutations with this group, which the scientists claimed was further evidence it had emerged in mice.
Professor Jianguo Xu, from China’s National Institute for Communicable Diseases, said Omicron’s mutation profile ‘shows that the virus has adapted to infect the cells of mice’.
He added: ‘We believe that Covid slowly accumulated mutations over time in mice, before it was transmitted back to humans by reverse zoonotic.
‘These findings suggest that researchers should focus on SARS-CoV-2 variants isolated from wild animals, especially rodents.
‘If Omicron is determined to have been derived from mice, the implications of it circulating among non-human hosts will pose new challenges in the prevention and control of the epidemic.’
Some scientists — including Professor Kristian Andersen at the US-based Scripps Research Institute — have suggested that Omicron may have emerged in mice.
They argue this could explain why it carries so many mutations that are radically different from other variants.
But the argument is yet to gain much traction among scientists.
Many still argue it likely emerged either in an immunocompromised patient or in an area where Covid surveillance is very poor.
The study was published in the Journal of Biosafety and Biosecurity.